Ashton Thomas Securities LLC Makes New Investment in BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Posted by Lindsey Winhoffer on Nov 13th, 2024

Ashton Thomas Securities LLC purchased a new stake in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 9,500 shares of the company’s stock, valued at approximately $156,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in BCAT. Oppenheimer & Co. Inc. increased its stake in BlackRock Capital Allocation Term Trust by 18.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock valued at $486,000 after purchasing an additional 4,586 shares in the last quarter. Ironsides Asset Advisors LLC raised its stake in shares of BlackRock Capital Allocation Term Trust by 14.1% during the 1st quarter. Ironsides Asset Advisors LLC now owns 29,133 shares of the company’s stock worth $485,000 after buying an additional 3,606 shares during the last quarter. Advisors Asset Management Inc. boosted its position in shares of BlackRock Capital Allocation Term Trust by 9.1% in the 1st quarter. Advisors Asset Management Inc. now owns 189,291 shares of the company’s stock worth $3,154,000 after buying an additional 15,763 shares in the last quarter. Alpine Global Management LLC grew its stake in BlackRock Capital Allocation Term Trust by 11.9% in the 1st quarter. Alpine Global Management LLC now owns 151,000 shares of the company’s stock valued at $2,516,000 after acquiring an additional 16,000 shares during the last quarter. Finally, Transcend Capital Advisors LLC increased its holdings in BlackRock Capital Allocation Term Trust by 7.3% during the 2nd quarter. Transcend Capital Advisors LLC now owns 65,207 shares of the company’s stock valued at $1,070,000 after acquiring an additional 4,435 shares in the last quarter. Institutional investors and hedge funds own 36.12% of the company’s stock.

Insider Buying and Selling

In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. sold 166,128 shares of the company’s stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $16.60, for a total value of $2,757,724.80. Following the transaction, the insider now directly owns 15,096,159 shares in the company, valued at approximately $250,596,239.40. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last quarter, insiders sold 723,927 shares of company stock worth $11,925,047.

BlackRock Capital Allocation Term Trust Stock Down 0.3 %

Shares of NYSE BCAT opened at $16.29 on Wednesday. The firm’s 50-day moving average is $16.30 and its two-hundred day moving average is $16.30. BlackRock Capital Allocation Term Trust has a 12-month low of $14.53 and a 12-month high of $17.18.

BlackRock Capital Allocation Term Trust Increases Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be given a $0.2885 dividend. This is an increase from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. This represents a $3.46 annualized dividend and a dividend yield of 21.26%. The ex-dividend date is Friday, November 15th.